Use access key #2 to skip to page content.
$3.51 0.25 (7.67%)
7/8/2008 4:00 PM

ACADIA Pharmaceuticals, Inc. (ACAD)

CAPS Rating:
**

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

View All Commentary (ACAD)

Recs

0

Avatar bobby410 (< 20) Submitted: 12/04/07 5:35 PM : Outperform Start Price: $11.63 ACAD Score: -55.81

Have a friend who works there, & things are looking very very good.


Report this Post Replies: 0 | Reply

Featured Broker Partners